Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Bluebird Bio (BLUE) has shared an update.
Bluebird bio, Inc. has strengthened its board with the appointment of Michael Cloonan as a new Class I director starting June 20, 2024. Cloonan is set to receive an annual retainer and equity compensation in line with the company’s policy for non-employee directors, with his stock options and restricted stock units vesting over a three-year period. His appointment comes with a standard indemnification agreement, and there are no familial or undisclosed financial ties between him and the current company leadership or transactions that would necessitate regulatory disclosure.
For an in-depth examination of BLUE stock, go to TipRanks’ Stock Analysis page.